Evaluation strategy of complete response after neoadjuvant therapy for rectal cancer.
10.3760/cma.j.cn112139-20230417-00171
- VernacularTitle:直肠癌新辅助治疗后完全缓解的评价策略现状及探索
- Author:
J G HAN
1
;
Z J WANG
1
Author Information
1. Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Neoadjuvant Therapy;
Treatment Outcome;
Neoplasm Recurrence, Local/diagnosis*;
Watchful Waiting;
Rectal Neoplasms/surgery*;
Chemoradiotherapy
- From:
Chinese Journal of Surgery
2023;61(9):738-743
- CountryChina
- Language:Chinese
-
Abstract:
Currently, the standard of clinical complete response (cCR) after neoadjuvant chemoradiotherapy (nCRT) for local advanced rectal cancer generally lacks pathological examination, the cCR judged by the current standard is still far from the real pathological complete response. After nCRT, due to the presence of tissue edema and fibrosis, MRI is highly uncertain in determining the staging of local lesions. The precision of colonoscopy biopsy is generally low because residual cancer foci exist primarily in the muscular layer, which limits the determination of cCR by colonoscopy biopsy. Local excision through the anus can resect the whole intestinal wall tissue, which is relatively accurate and close to the real state of remission of the lesion, but there are many problems, such as affecting anal function, high rate of complications, and increased difficulty of following radical surgery. Based on the present diagnosis of cCR, the authors put forward the concept of modified cCR (m-cCR) which combined with the pathological standard of transanal multipoint full-layer puncture biopsy. It is possible to improve the accuracy of cCR, and improve the safety of cCR patients who receive wait-and-watch therapy without increasing complications or affecting anal function. The exact conclusion needs to be confirmed by further studies.
